Finkelstein, David I.

Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ

Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 672

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Lei, P., Ayton, S., Finkelstein, D. I., Spoerri, L., Ciccotosto, G. D., Wright, D. K., Wong, B. X. W., Adlard, P. A., Cherny, R. A., Lam, L. Q., et al. (2012) · Nature Medicine

Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments

Cited by 594

Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease

Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 264

Motor and cognitive deficits in aged tau knockout mice in two background strains

Lei, P., Ayton, S., Moon, S., Zhang, Q., Volitakis, I., Finkelstein, D. I., & Bush, A. I. (2014) · Molecular Neurodegeneration

Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments

Cited by 145

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies

Kawahata, I., Finkelstein, D. I., & Fukunaga, K. (2022) · International Journal of Molecular Sciences

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 102

A review of β-amyloid neuroimaging in Alzheimer's disease

Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 93

Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers

Ugalde, C. L., Finkelstein, D. I., Lawson, V. A., & Hill, A. F. (2016) · Journal of Neurochemistry

Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatments

Cited by 92

Type‐1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease

Main, B. S., Zhang, M., Brody, K. M., Ayton, S., Frugier, T., Steer, D., Finkelstein, D., Crack, P. J., & Taylor, J. M. (2016) · Glia

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 92

Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

Hare, D. J., Adlard, P. A., Doble, P. A., & Finkelstein, D. I. (2013) · Metallomics

Parkinson's Disease Mechanisms and TreatmentsHeavy Metal Exposure and Toxicity

Cited by 78

Targeting the Progression of Parkinsons Disease

George, J., Mok, S., Moses, D., Wilkins, S., Bush, A., Cherny, R., & Finkelstein, D. (2009) · Current Neuropharmacology

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 77

Glia and zinc in ageing and Alzheimer’s disease: a mechanism for cognitive decline?

Hancock, S. M., Finkelstein, D. I., & Adlard, P. A. (2014) · Frontiers in Aging Neuroscience

Trace Elements in HealthAlzheimer's disease research and treatments

Cited by 42